ReviewDrug safety2011
A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.
Sam Schulman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewDrug safety2011
Sam Schulman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.